Kayne Anderson Capital Advisors
BMEZ icon

Kayne Anderson Capital Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Kayne Anderson Capital Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-36,000
Closed -$527K – 67
2023
Q4 		$527K Hold
36,000
– – 0.02% 69
2023
Q3 		$519K Buy
+36,000
New +$561K 0.02% 75

Other funds holding BMEZ

Saba Capital Management
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sit Investment Associates
Sit Investment Associates Minneapolis, Minnesota $5.28B AUM 14.42% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Sessa Capital
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Karpus Investment Management
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return

Kayne Anderson Capital Advisors's BMEZ Position: Q1 2024 in Review

Kayne Anderson Capital Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q1 2024, closing a stake of 36,000 shares — an estimated $527K sold.

Kayne Anderson Capital Advisors first reported a position in BMEZ in Q3 2023 and held it in 2 quarters. The position peaked at $527K in Q4 2023. 99 funds tracked by Wall St. Rank hold BMEZ as of Q1 2024.

  • Kayne Anderson Capital Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q1 2024 after selling out during the quarter.
  • Kayne Anderson Capital Advisors sold 36,000 BlackRock Health Sciences Trust II shares in Q1 2024, an estimated $527K.
  • Kayne Anderson Capital Advisors first reported a position in BlackRock Health Sciences Trust II in Q3 2023 and held it in 2 quarters.
  • Kayne Anderson Capital Advisors's BlackRock Health Sciences Trust II position peaked at $527K in Q4 2023.
  • 99 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q1 2024.

Based on Kayne Anderson Capital Advisors's 13F filing for Q1 2024, filed 6 May 2024.